Clinical Study
in NAION
To find out if you may be eligible for the study, please fill out a quick survey.

We are evaluating the safety and efficacy of an investigational drug to stop further vision loss in patients with early diagnosis of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION). NAION is the most common cause of sudden optic nerve related vision loss in older individuals.

Criteria for Study Participation

  • Aged 50 to 80 years old
  • Experienced sudden vision loss in the last 14 days
  • No treatment for current set of vision loss symptoms
  • Other criteria to be evaluated at the clinical site

If you are experiencing vision loss, contact a medical professional as soon as possible.

Breaking mists, the Pap of Glen Coe
Artist: Keith Salmon